Medivir

7,478SEK +6,81 %
Vær den første som følger denne virksomhed

Medivir is a pharmaceutical company. The company develops drugs and treatments with a focus on cancers and other serious diseases. The company invests in indication areas where available treatment methods are limited or where they are completely lacking research. Collaborations with other partners are part of the business model, and drug development, as well as commercialization, are conducted either in-house or in partnership with other pharmaceutical companies. The head office is located in Huddinge.

Læs mere
Omsætning
4,4 mio.
EBIT %
-1.986,36 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
MVIR
Daglig lav / høj pris
7,001 / 7,5 SEK
Markedsværdi
417,58 mio. SEK
Aktieomsætning
265,75 t SEK
Volumen
36 t
Publisher
Medivir, Capital Markets Day, 2023

Videopræsentation09.03.2023